Gingival Recession (RT1) Treatment With Different Gingival Augmentation Surgeries

This parallel arm randomized controlled clinical trial study will include systematically free patients with thin gingival phenotype. They will be randomly allocated to three equal groups. Group A (test group, n=10) will receive non-surgical periodontal treatment and connective tissue graft using tunneling technique, Group B (test group, n=10) will receive non-surgical periodontal treatment and partially de-epithelized free gingival graft, while group C (control group, n=10) will receive non-surgical periodontal treatment only. After 3, 6 and 12 months gingival biotype will be clinically assessed (1ry outcome). This parameter will be recorded at baseline, 3, 6 and 12 months. The 2ry outcomes will include recording of recession depth, plaque index, bleeding on probing, keratinized tissue width . Postoperative pain and swelling will be recorded daily by the patient for the 1st two weeks post-surgically. Postoperative instructions and medication will be given to the patient. All readings will be carried out by a calibrated outcome assessor who will be masked. Follow-up will be performed to assess the outcomes and to ensure performing proper oral hygiene. Data collected will be tabulated and statistically analyzed.

Inclusion criteria

• Medically free patients (American Society of Anesthesiologists I; ASA I)
• Patients diagnosed with recession (RT1)
• Fair oral hygiene
• Patient accepting to provides an informed consent and the follow-up

Exclusion criteria

• Carious teeth and teeth with periapical infection.
• Patients diagnosed with periodontitis
• Smokers
• Pregnant and lactating females